The outlook for children diagnosed with B-cell acute lymphoblastic leukaemia (B-ALL) is poor because there is a lack of knowledge about how the disease occurs in children. Prof. Katrin Ottersbach is investigating the role of chromosomal rearrangement in B-ALL, as well as the roles of the immune system and infections in the development of childhood leukaemia more widely. Her findings could help to develop new and more precise therapies to give children a better chance of survival from leukaemia. We’re partnering with Cancer Research UK to co-fund this £1.3 million programme of research.
Investigating how childhood leukaemia develops
Prof. Katrin Ottersbach
University of Edinburgh
Edinburgh, EH16 4UU
1 April 2017
£313,000 (This project is co-funded with Cancer Research UK. The total cost of the project is £1,353,428.85).